Clinical Trial

Breast Aesthetics by Three Dimensional Measures

Active, Not Recruiting
View on ClinicalTrials.gov →
Summary
Traditionally the measures of the optimally aesthetic breast have been assumed to be static and to represent universal values (1). Measures developed for optimal aesthetic results in breast reduction were derived from brassiere patterns and then applied universally (2). These early and important papers still strongly influence the view of the aesthetics of the breast despite the lack of individualisation and proportion. To create satisfying results for specific patients, optimal proportions angles and relative measures are needed for each patient. The study will clarify theses measures and provide important guidelines for surgeons.The data will also help define optimal proportional aesthetics in the individual patient. The concept of universal beauty is unrealistic. It has always been taken for granted that aesthetic values from all cultures are similar. Using 3D scanning on volunteers of youthful age offers a complex set of data that may distinguish fine differences in aesthetic ideals in different cultures. Little is known about how life events and life-style factors affect breast aesthetics. To follow a population with 3D scans over 5, 10 and 15 years will allow aesthetic ratings to be correlated with life events such as pregnancy, childbirth, breast-feeding and life style factors such as smoking. The study will improve the understanding of breast aesthetics in general, in different cultures and in relation to life events and life style factors. No similar studies have previously been performed.
Protocol Amendment History 4 amendments
This ClinicalTrials.gov record has been amended 4 times since 2018-06-23; most recent amendment 2025-07-03.
Status change: Recruiting → Active, Not Recruiting 2019-12-08
Trial Details
NCT Number NCT03578484
Lead Sponsor Sykehuset Telemark
Collaborators: M.D. Anderson Cancer Center, University College of Southeast Norway, Skintech A/S, Canfield Inc, Oslo University Hospital, Karolinska Institutet, University of Helsinki
Conditions Breast Cancer
Enrollment 32 participants
Start Date 2016-05-13
Primary Completion 2032-03-20 (estimated)
Study Completion 2032-03-20 (estimated)
Updated on ClinicalTrials.gov 2025-07-04